小智港股覆盤 | 7月8日
今日，港股三大指數集體上漲。截止收盤，恆生指數漲0.38%，報21725點。國企指數漲0.17%，報7551點。恆生科技指數漲0.59%，報4808點。市場約906只個股上漲，702只個股下跌。成交額突破1058.54億港幣，和昨天同期相比下跌5.54%。南下資金淨流入6.54億港幣。
盤面上，專業服務板塊集體拉昇。今海國際漲超15%；人瑞人才漲超4%；仁德資源漲超3%；WAC HOLDINGS、中安控股集團等多股漲超2%。
互聯網醫療板塊跟隨走強。白花油漲超6%；石藥集團、雅各臣科研製藥等多股漲超5%；復星醫藥、綠葉製藥等多股漲超3%。石藥集團升近6%，首款大分子單抗藥正式申報上市，機構指創新藥管線料加速2022-2024財年盈利增長；雅各臣科研製藥續漲逾5%現六連陽，全年股東應佔溢利同比增長2.3%至1.78億港元；復星醫藥午後升逾4.6%，ET-26啓動II期臨牀試驗。
半導體板塊走高。中國環保科技漲超13%；中國水務漲超3%；中國水業集團、粵海投資等多股漲超2%；北控水務集團漲超1%。中國水務漲超5%，直飲水業務表現亮眼，星展升其目標價至10.4港元。
CRO板塊走低。國美金融科技跌超3%；香港信貸跌超2%。
生物科技板塊走低。藥明生物跌超3%；金斯瑞生物科技跌超2%；康龍化成跌超1%。大和上調藥明生物目標價32%至95港元，料其近期市場情緒回升。
造紙林業板塊走弱。信保環球控股跌超5%；玖龍紙業跌超2%；脈資資源、世大控股等多股跌超1%。
uSMART智能寫手的信息、數據均來自媒體公開報道，智能寫手不能保證其完全準確，內容僅供參考，不構成投資建議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
